Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse
Chun Yew Fong(Olivia Newton-John Cancer Wellness & Research Centre), Andrew H. Wei(The Royal Melbourne Hospital), Philip Campbell(Barwon Health), John Coutsouvelis(The Alfred Hospital), Patricia Walker(The Alfred Hospital), Sushrut Patil(Alfred Health), Anthony P. Schwarer(The Alfred Hospital), Sharon Avery(The Alfred Hospital), Jenny Muirhead(The Alfred Hospital), George Grigoriadis(Hudson Institute of Medical Research), Andrew Spencer(The Alfred Hospital), Jay Hocking(Box Hill Hospital), Eldho Paul(Monash Health)
Cited by 15
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k